Relfydess, 100 units/mL, solution for injection
*Company:
Galderma International S.A.S. c/o Galderma (U.K) Ltd.Status:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 15 July 2026
File name
90-52064-03_Single Leaflet_Relfydess_IE.pdf
Reasons for updating
- Change to section 6 - what the product contains
Updated on 15 July 2026
File name
ie-spc-relfydess-en-clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.9 - Overdose
- Change to section 6.1 - List of excipients
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 May 2026
File name
90-52064-02_Single Leaflet_Relfydess_IE (6).pdf
Reasons for updating
- New PIL for new product
Updated on 14 May 2026
File name
ie-spc-clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
Address:
Galderma (U.K.) Limited, 1 Triton Square, London, England, NW1 3DXMedical Information E-mail:
medinfo.uk@galderma.comTelephone:
+44 (0)300 3035674